Sunday, March 4, 2012

Proteome sciences, IDEXX enter deal to develop BSE diagnostic.

LONDON -- Proteome Sciences plc is making strides in its bid to commercialize its proteomics research, entering a licensing agreement that grants exclusive rights to bovine spongiform encephalopathy (BSE) blood biomarkers to IDEXX Laboratories Inc., one of the world's largest veterinary diagnostics company.

A company spokesman told BioWorld International, "We had people queuing up to do a deal with us. We chose IDEXX because they are the biggest." The terms were not disclosed but the spokesman said it was a significant deal including up-front and milestone payments and double-digit royalty rates from the Westbrook, Maine, company.

Developing a test around the …

No comments:

Post a Comment